- Home
- LRFC vs IPA Comparison
LRFC vs IPA Comparison
Compare LRFC & IPA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRFC
- IPA
- Stock Information
- Founded
- LRFC 2013
- IPA 1983
- Country
- LRFC United States
- IPA United States
- Employees
- LRFC N/A
- IPA N/A
- Industry
- LRFC Finance: Consumer Services
- IPA Biotechnology: Pharmaceutical Preparations
- Sector
- LRFC Finance
- IPA Health Care
- Exchange
- LRFC Nasdaq
- IPA Nasdaq
- Market Cap
- LRFC 50.2M
- IPA 46.0M
- IPO Year
- LRFC 2013
- IPA 2017
- Fundamental
- Price
- LRFC $18.86
- IPA $1.09
- Analyst Decision
- LRFC
- IPA Strong Buy
- Analyst Count
- LRFC 0
- IPA 2
- Target Price
- LRFC N/A
- IPA $4.00
- AVG Volume (30 Days)
- LRFC 11.2K
- IPA 4.9M
- Earning Date
- LRFC 08-07-2025
- IPA 07-28-2025
- Dividend Yield
- LRFC 7.58%
- IPA N/A
- EPS Growth
- LRFC N/A
- IPA N/A
- EPS
- LRFC N/A
- IPA N/A
- Revenue
- LRFC $20,544,000.00
- IPA $16,581,105.00
- Revenue This Year
- LRFC N/A
- IPA $4.67
- Revenue Next Year
- LRFC N/A
- IPA $14.15
- P/E Ratio
- LRFC N/A
- IPA N/A
- Revenue Growth
- LRFC 3.11
- IPA 1.34
- 52 Week Low
- LRFC $16.57
- IPA $0.27
- 52 Week High
- LRFC $26.00
- IPA $1.16
- Technical
- Relative Strength Index (RSI)
- LRFC 56.05
- IPA 73.09
- Support Level
- LRFC $18.53
- IPA $1.03
- Resistance Level
- LRFC $19.00
- IPA $1.16
- Average True Range (ATR)
- LRFC 0.39
- IPA 0.14
- MACD
- LRFC 0.18
- IPA 0.02
- Stochastic Oscillator
- LRFC 77.87
- IPA 87.69
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.
About IPA ImmunoPrecise Antibodies Ltd.
ImmunoPrecise Antibodies Ltd is a techbio company that leverages multi-omics modeling and complex artificial intelligence through a series of proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe.